If you live with atrial fibrillation, often called AFib, you have likely heard that the condition raises the risk of stroke and that blood thinners are the standard way to reduce it. For many people, blood thinners work well and cause little trouble. But for others, these medications cause bleeding problems, are difficult to tolerate, or simply are not a good fit for their lives. For those patients, a procedure called left atrial appendage closure offers an alternative worth understanding. The most widely known device for this is the Watchman, and learning how it works can help you have a more informed conversation with your care team.
Why AFib Raises Stroke Risk
In a healthy heart, the upper chambers contract in a coordinated rhythm that moves blood efficiently into the lower chambers. In AFib, the upper chambers quiver instead of contracting cleanly. When blood does not move smoothly, it can pool and form clots. A small pouch off the left upper chamber, called the left atrial appendage, is where the large majority of these clots form in people with AFib that is not caused by a heart valve problem.
If a clot travels from this pouch to the brain, it can cause a stroke. Blood thinners work by making clots far less likely to form anywhere in the body, which is why they are the standard treatment and why they are so effective. The trade-off is that the same effect that prevents clots also increases the risk of bleeding, and for some people that trade-off becomes difficult to live with over many years.
How Left Atrial Appendage Closure Works
Left atrial appendage closure takes a different approach. Rather than thinning the blood throughout the body, the procedure seals off the appendage itself, so clots cannot form there or escape into the circulation. The Watchman is a small, umbrella-shaped device that is placed inside the opening of the appendage to close it.
The procedure is performed through a catheter, a thin flexible tube guided through a vein in the leg up to the heart. There is no open-chest surgery involved, and most people are surprised by how straightforward the experience is. Once the device is positioned at the mouth of the appendage, heart tissue gradually grows over it during the weeks that follow, permanently sealing the pouch. Most patients stay in the hospital briefly, often just overnight, and return to normal activities quickly.
What happens to blood thinners afterward
One of the main goals of the procedure is to allow many patients to stop long-term blood thinners. There is usually a transition period after placement during which medication continues while the device seals, after which it can often be reduced or discontinued under careful supervision. The exact plan depends on your individual situation and should be discussed in detail, because the timing of stopping medication is an important safety consideration rather than an afterthought. During the sealing period, follow-up imaging is typically performed to confirm that the device is in good position and that the appendage is fully closed before any medication is reduced. This careful, step-by-step approach is what allows the procedure to deliver its main benefit, the eventual freedom from long-term blood thinners, without exposing you to unnecessary risk in the meantime. Your team will explain exactly what to watch for and when each follow-up will occur.
Who Might Be a Good Candidate
Left atrial appendage closure is not for everyone with AFib. It is generally considered for people who have AFib not related to a heart valve problem, who have a meaningful stroke risk, and who have a good reason to avoid long-term blood thinners. Common reasons include:
- A history of serious or recurrent bleeding while taking blood thinners.
- A high risk of bleeding due to other medical conditions or a tendency to fall.
- An occupation or lifestyle that makes bleeding risk especially concerning.
- Difficulty tolerating or consistently taking the medication.
On the other hand, if you tolerate blood thinners well and have no bleeding concerns, continuing medication may remain the most sensible path, and there is no need to pursue a procedure simply because it exists. The decision is genuinely individual, and it benefits from an honest assessment of your stroke risk and bleeding risk together. Our risk calculator can help you and your family begin to weigh these factors before a consultation.
Questions to discuss before deciding
Before choosing left atrial appendage closure, consider raising these points with your care team: What is my individual stroke risk, and how does it compare with my bleeding risk? Have all reasonable medication options been tried or considered first? How experienced is this team specifically with closure procedures? What will my medication plan look like in the months after the procedure? And are there features of my heart's anatomy that make me a better or poorer candidate? Clear answers to these questions are the mark of a trustworthy recommendation.
Understanding the Benefits and Risks
For the right patient, left atrial appendage closure can provide stroke protection comparable to blood thinners while reducing the long-term risk of bleeding. That combination is appealing, particularly for people who have already experienced bleeding complications and feel caught between two risks.
Like any heart procedure, it carries risks that deserve a clear explanation. These can include bleeding at the catheter site, fluid around the heart, or, rarely, an issue with device placement. Experienced operators and centers keep these risks low, which is one reason it is worth asking how frequently a given team performs the procedure. A balanced conversation about both the upside and the potential complications is essential, and any physician recommending the procedure should welcome those questions rather than rush past them. You can learn more about evaluating treatment options in our learning center. If you are uncertain whether the procedure is truly the best step for you, that uncertainty is worth resolving before scheduling anything, and a cardiac second opinion can confirm that closure is appropriate or clarify whether another approach fits better.
Why Two Perspectives Help, and Your Next Step
Decisions about AFib and stroke prevention involve careful balancing of competing risks, and reasonable specialists can weigh them differently. Having your records reviewed by both a cardiologist and a cardiac surgeon means you benefit from complementary expertise: the cardiologist's deep familiarity with rhythm management and catheter-based options, and the surgeon's broader view of how your overall cardiac picture fits together. This dual-physician model is the foundation of the WhiteGloveMD Heart Team, where every review pairs an experienced cardiologist with a cardiac surgeon so that decisions like left atrial appendage closure are examined thoroughly, with your specific risks and goals in mind. You can see how the process works on our how it works page.
Choosing how to prevent stroke in AFib is a personal decision that deserves clear, unbiased guidance. Whether you are considering the Watchman, weighing it against continuing blood thinners, or simply want reassurance that your current plan is sound, an independent expert review can bring real peace of mind. WhiteGloveMD provides a dual-physician Heart Team review starting at From $500, with a 24-hour review after your records are received. Request a call to discuss your options, or review our transparent pricing to choose what works for you.